Assessment of indirect medical costs within the first three years of rheumatoid arthritis: comparison of current methodological approaches. - Merkesdal,S.; Ruof,J.; Mittendorf,T.; Zeidler,H.; Mau,W. (Expert Rev Pharmacoeconomics Outcomes Res, 2002)